| 000 | 01858 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250511175810.0 | ||
| 264 | 0 | _c19920304 | |
| 008 | 199203s 0 0 eng d | ||
| 022 | _a0004-0010 | ||
| 024 | 7 |
_a10.1001/archsurg.1992.01420010065009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStratta, R J | |
| 245 | 0 | 0 |
_aA randomized prospective trial of acyclovir and immune globulin prophylaxis in liver transplant recipients receiving OKT3 therapy. _h[electronic resource] |
| 260 |
_bArchives of surgery (Chicago, Ill. : 1960) _cJan 1992 |
||
| 300 |
_a55-63; discussion 63-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAcyclovir _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Viral _xanalysis |
| 650 | 0 | 4 |
_aAntigens, Differentiation, T-Lymphocyte _xanalysis |
| 650 | 0 | 4 | _aCD3 Complex |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCytomegalovirus _ximmunology |
| 650 | 0 | 4 | _aDrug Costs |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xtherapeutic use |
| 650 | 0 | 4 |
_aLiver Transplantation _xmortality |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMuromonab-CD3 _xadverse effects |
| 650 | 0 | 4 |
_aOpportunistic Infections _ximmunology |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _xanalysis |
| 650 | 0 | 4 | _aT-Lymphocyte Subsets |
| 700 | 1 | _aShaefer, M S | |
| 700 | 1 | _aCushing, K A | |
| 700 | 1 | _aMarkin, R S | |
| 700 | 1 | _aReed, E C | |
| 700 | 1 | _aLangnas, A N | |
| 700 | 1 | _aPillen, T J | |
| 700 | 1 | _aShaw, B W | |
| 773 | 0 |
_tArchives of surgery (Chicago, Ill. : 1960) _gvol. 127 _gno. 1 _gp. 55-63; discussion 63-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/archsurg.1992.01420010065009 _zAvailable from publisher's website |
| 999 |
_c1316908 _d1316908 |
||